TY  - JOUR
T1  - Sol Vetrikül destek cihazı olan hastalarda sağ kalp yetmezliği ile sol vetrikül destek cihazı trombozu arasında ilişki var mıdır?
TT  - Is there a relationship between right heart failure and left ventricular assist device thrombosis in patient with left ventricular assist device ?
AU  - Beyazpınar, Deniz Sarp
AU  - Günertem, Eren
AU  - Ersoy, Özgür
AU  - İnce, İlker
PY  - 2023
DA  - September
DO  - 10.18663/tjcl.1335269
JF  - Turkish Journal of Clinics and Laboratory
JO  - TJCL
PB  - DNT Ortadoğu Yayıncılık A.Ş.
WT  - DergiPark
SN  - 2149-8296
SP  - 540
EP  - 543
VL  - 14
IS  - 3
LA  - tr
AB  - Amaç: Sol ventrikül destek cihazı (LVAD) ileri dönem kalp yetmezliği tedavisinde kullanılan metodlardan biridir. Erken dönemde kalp nakline köprülemek amacı ile kullanılan sol ventrikül destek cihazları kalp nakli verici sayısının kısıtlı olması sebebi ile artık destinasyon tedavisi olarak kullanımı her geçen gün artmaktadır. LVAD ile geçirilen süre uzadıkça komplikasyonlarda artmaktadır. Bu komplikasyonlardan en mortal olanı LVAD trombozudur. Bu mortal komplikasyonun önlenebilmesi amacı ile risk faktörlerinin aydınlatılması çok önemlidir.  Gereç ve Yöntemler: Nisan  2012 ile ocak 2020 tarihleri arasında, toplam  80 LVAD hastası retrospektif olarak değerlendirilmiştir. Hastaların veri tabanından demografik özellikleri, yandaş hastalıkları, preoperatif tetkikleri, LVAD data kayıtları kayıt altına alınılmıştır. Sağ ventrikülün kasılma fonksiyonlarını değerlendirmek amacı ile ameliyat öncesi dönemde yapılmış olan ekokardiyogram tetkiklerinde triküspid kapak anüluler hareketinin ölçümü (TAPSE) değeri kullanılmıştır.  Bulgular: Çalışmaya toplam 60 hasta dahil edilmiştir. Bu hastalardan sağ ventrikül fonksiyonları, normal veya hafif etkilenmiş olan (TAPSE≥17) ve orta veya ileri etkilenmiş (TAPSE
KW  - LVAD
KW  - lvad tromboz
KW  - sağ ventrikül yetmezliği
N2  - Aim: Left ventricular assist device (LVAD)is one of the treatment method of advanced heart failure. LVAD, which are used to bridge heart transplantation in the early period, are now increasingly used as destination therapy due to the limited number of heart transplant donors. As the time spent with LVAD increases, complications increase. The most mortal of these complications is LVAD thrombosis. It is very important to clarify the risk factors in order to prevent this mprtal complication.Material and Methods: Between April 2012 and January 2020, a total of 80 LVAD patients were evaluated retrospectively. Demographic characteristics, co-morbidities, preoperative examinations, LVAD data records of the patients were recorded from the database. Tricuspid valvw annular motion measurement (TAPSE) value was used in echogradiogram examinations performed in the preoperative period to evaluate the contractile functions of the right ventricle.Results: A total of 60 patients included in the study. Patients divided into two according to right ventricular functions. Normal or mildly affected right ventricular functions (TAPSE≥17) and modarete or severely affected right ventricular functions (TAPSE
CR  - Hohner E, Crow J, Moranville MP. Medication management for left ventricular assist device thrombosis. Am J Health Syst Pharm. 2015;72(13):1104-1113.
CR  - Mohamedali B, Bhat G. Theinfluence of pre-leftventricularassistdevice (LVAD) implantationglomerularfiltration rate on long-term LVAD outcomes. HeartLungCirc 2017;26:1216-23.
CR  - Borgi J, Tsiouris A, Hodari A, Cogan CM, Paone G, Morgan JA. Significance of postoperativeacuterenalfailureaftercontinuous-flowleftventricularassistdeviceimplantation. AnnThoracSurg 2013;95:163-9.
CR  - Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular asist device: incidence, risk factors, and effect on outcomes. J ThoracCardiovascSurg 2010;139:1316-24.
CR  - Baumwol J, Macdonald PS, Keogh AM, et al. Right heart failure and “failure to thrive” after left ventricular asist device: clinical predictors and outcomes. J HeartLungTransplant 2011;30:888-95.
CR  - Dang NC, Topkara VK, Mercando M et al. Right heart failure after left ventricular asist device implantation in patients with chronic congestive heart failure. J HeartLungTransplant 2006;25:1-6.
CR  - Beyazpınar DS, Ersoy O, Gültekin B, Aliyev A, Avsever M, Akay HT, Özkan M, Sezgin A, Aşlamacı S.Treatment of Left Ventricular Assist Device Thrombosis: Single-Center Experience. ExperimentalandClinicalTransplantation 2018; Suppl1: 165-167
CR  - Najjar SS, Slaughter MS, Pagani FD, et al; HVAD Bridge to Transplant ADVANCE Trial Investigators: An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant 33: 23–34, 2014.
CR  - Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885-96.
CR  - Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J AmColl Cardiol 2009;54:312-21.
CR  - Potapov E, Meyer D, Swaminathan M, et al. Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, doubleblind, multicenter, placebo-controlled trial. J Heart Lung Transplant 2011;30:870-8.
CR  - Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885-96.
CR  - Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J AmColl Cardiol 2009;54:312-21.
CR  - Potapov E, Meyer D, Swaminathan M, et al. Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, doubleblind, multicenter, placebo-controlled trial. J Heart Lung Transplant 2011;30:870-8.
UR  - https://doi.org/10.18663/tjcl.1335269
L1  - https://dergipark.org.tr/tr/download/article-file/3297802
ER  -